TMCnet News

CRO Quality Benchmarking - Phase II/III Service Providers (2016 Edition) - Research and Markets
[November 30, 2016]

CRO Quality Benchmarking - Phase II/III Service Providers (2016 Edition) - Research and Markets


Research and Markets has announced the addition of the "CRO Quality Benchmarking - Phase II/III Service Providers (8th edition)" report to their offering.

The CRO Quality Benchmarking - Phase II/III Service Providers report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their own experiences with 44 Phase II/III CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 8th year, this report has become a crucial tool for sponsors looking to select a Phase IV CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.

Study Sponsors:

- Make a more informed purchase of Phase II/III services by understanding which service providers best fit your company's needs

- Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes

- Pinpoint potential delivery concerns early in a sponsor-CRO relationship/ evaluation in order todevelop proactive strategies to address potential gaps



Clinical Service Providers:

- Uncover your own - and competitor - delivery strengths and weaknesses


- Design messaging to tout your company's strengths

- Compete more effectively by understanding buyers' selection criteria and outsourcing trends

Key Topics Covered:

1. Introduction

2. Methodology

3. Respondent Demographics And Qualifications

4. Number Of Ratings Per Company

5. 5 Major Sections

6. Service Provider Selection Process

7. Service Provider Perceptions And Interactions (News - Alert)

8. Service Provider Performance And Loyalty

9. Company Service Quality Profiles

10. Study Data

11. Demographics

Companies Mentioned

  • Accell
  • Accelovance
  • Accenture (News - Alert)
  • Chiltern
  • Clinical Research Services (CRS)
  • Cognizant
  • Covance
  • DaVita Clinical Research
  • DCRI - Duke
  • Encorium
  • Eurofins
  • Eurotrials
  • Frontage
  • ICON
  • Inamed
  • INC Research
  • inVentiv Health Clinical
  • KCR
  • Lambda
  • Medpace
  • Medsource
  • NAMSA
  • Novotech
  • PAREXEL
  • Pharm-Olam International
  • PPD
  • PRA
  • Premier Research
  • ProTrials
  • Symbio (News - Alert)
  • SynteractHCR
  • Tata
  • Theorem
  • TKL Research
  • Worldwide Clinical Trials

For more information about this report visit http://www.researchandmarkets.com/research/6mkltf/cro_quality


[ Back To TMCnet.com's Homepage ]